Show Summary Details
Page of

Cannabinoids and Cancer 

Cannabinoids and Cancer
Cannabinoids and Cancer

Donald I. Abrams

and Manuel Guzman

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 26 September 2020

Chapter 8 discusses cannabinoids and cancer, including the use of cannabis in medicine for thousands of years prior to its current status as an illicit substance, that cannabinoids, the active components of Cannabis sativa, mimic the effects of the endogenous cannabinoids, how Delta-9-tetrahydrocannabinol, the main bioactive cannabinoid in the plant, has been available as a prescription medication approved for chemotherapy-induced nausea and vomiting and treatment of anorexia associated with the AIDS wasting syndrome, that cannabinoids may be of benefit in the treatment of cancer-related pain, possibly in a synergistic fashion with opioid analgesics, that cannabinoids have a favorable drug safety profile, medical use predominantly limited by their psychoactive effects and their limited bioavailability, the lack of conclusive evidence that chronic cannabis use leads to the development of any malignancies, that cannabinoids inhibit tumor growth in laboratory animal models by modulation of key cell-signaling pathways, inducing direct growth arrest and tumor cell death, as well as by inhibiting tumor angiogenesis and metastasis, that cannabinoids appear to be selective antitumor compounds because they kill tumor cells without affecting their nontransformed counterparts, and the need for further research on the role of cannabinoids in palliative cancer care and as potential anti-cancer agents.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.